Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: A pilot study

Cytotherapy

Volumn 12, Issue 2, 2010, Pages 265-268

  Arima, Nobuyoshi ^a   Nakamura, Fumiaki ^a   Fukunaga, Akiko ^a   Hirata, Hirokazu ^a   MacHida, Hiroko ^b   Kouno, Shigene ^a   Ohgushi, Hajime ^b  

^a Kitano Hospital   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Graft versus host disease; Intra arterial therapy; Mesenchymal stromal cell

Indexed keywords

GANCICLOVIR; METHYLPREDNISOLONE; MORPHINE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL RESEARCH; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC PNEUMONIA SYNDROME; MALE; MESENCHYMAL STROMAL CELL; MICROANGIOPATHY; MYELOID LEUKEMIA; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; STROMA CELL; TARGET ORGAN; TOTAL PARENTERAL NUTRITION;

EID: 77749289235     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903390795     Document Type: Letter

References (12)

1. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-41.
2. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005;112:1451-61.
3. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92-5.
4. Shapira MY, Bloom AI, Or R, Sasson T, Nagler A, Resnick IB, et al. Intra-arterial catheter directed therapy for severe graft-versus-host disease. Br J Haematol. 2002;119:760-4.
5. Nakai K, Tajima K, Tanigawa N, Matsumoto N, Zen K, Nomura S, et al. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography. Bone Marrow Transplant. 2004; 33:1231-3.
6. Kotobuki N, Hirose M, Takakura Y, Ohgushi H. Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs. 2004;28:33-9.
7. Tadokoro M, Kanai R, Taketani T, Uchio Y, Yamaguchi S, Ohgushi H. New bone Formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. J Pediatr. 2009;154;924-30.
8. Kovacic JC, Graham RM. Stem-cell therapy for myocardial diseases. Lancet. 2004;363:1735-6.
9. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579-86.
10. von Bonin M, Stölzel F, Goedecke A, Richter K, Wuschek N, Hölig K, et al. Treatment of refractory acute GvHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245-51.
11. Ringden O, Le Blanc K. Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells. Biol Blood Marrow Transplant. 2006;12:693-94.
12. Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, Cugini D, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol. 2008;181:3933-46.